OKYO Pharma (OKYO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock OKYO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period China hands 3-1/2-year prison sentence to Astellas' Japanese employee, Nikkei saysJuly 16, 2025 | msn.comOKYO Pharma Ltd Financials - MorningstarJuly 3, 2025 | morningstar.comMOKYO Pharma Limited (OKYO) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: OKYO Pharma Limited Sponsored ADR (OKYO), Biogen (BIIB) and Cigna (CI)May 7, 2025 | theglobeandmail.comFDA grants fast track to OKYO Pharma’s neuropathic pain drugMay 2, 2025 | uk.investing.comOkyo Pharma announces data on long-term stability of urcosimodApril 1, 2025 | markets.businessinsider.comOkyo Pharma's OK-101 renamed urcosimod for eye painFebruary 12, 2025 | msn.comOKYO Pharma's lead asset receives USAN designation "urcosimodFebruary 12, 2025 | msn.comOKYO Pharma Announces OK-101 Officially Assigned USAN : UrcosimodFebruary 12, 2025 | markets.businessinsider.comH.C. Wainwright maintains Buy on OKYO Pharma with $7 targetFebruary 11, 2025 | msn.comMitsubishi Chemical sells pharmaceuticals subsidiary to Bain in $3.36 billion dealFebruary 8, 2025 | msn.comOkyo Pharma CEO purchases 10,000 shares of companyJanuary 31, 2025 | markets.businessinsider.comOKYO Pharma insiders buy shares amid clinical trialsJanuary 31, 2025 | msn.comOKYO Pharma advances neuropathic corneal pain drug trialJanuary 29, 2025 | msn.comOKYO Pharma Ltd LDecember 28, 2024 | investing.comAnalysts Are Bullish on These Healthcare Stocks: Veru (VERU), Ascendis Pharma (ASND)December 20, 2024 | markets.businessinsider.comOKYO Pharma to Present at International Tear Film and Ocular Surface Society ConferenceOctober 30, 2024 | markets.businessinsider.comOkyo Pharma announces first patient dosed in Phase 2 trial of OK-101October 23, 2024 | markets.businessinsider.comOptimistic Buy Rating for OKYO Pharma Limited Driven by Promising Phase 2 Trial of OK-101 in Unmet Medical Need for Neuropathic Corneal PainOctober 16, 2024 | markets.businessinsider.comOKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal PainOctober 16, 2024 | finance.yahoo.comOKYO Pharma (NASDAQ:OKYO) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comOKYO Pharma Granted U.S. Patent Covering OK-101's Potential for Treating Symptoms of Dry Eye DiseaseAugust 27, 2024 | finanznachrichten.deInvesco Global Equity Income Trust Plc - Transaction in Own SharesAugust 15, 2024 | uk.finance.yahoo.comA mysterious pile of bones could hide evidence of Japanese war crimes, activists sayJuly 27, 2024 | msn.comTokyo stocks end mixed on rising interest rates, firm U.S. futuresMay 28, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF) and Aslan Pharmaceuticals (ASLN)May 3, 2024 | markets.businessinsider.comA second Kobayashi Pharma Japan factory inspected over deathsMarch 31, 2024 | msn.comJapanese authorities inspect second Kobayashi Pharma factory after deathsMarch 31, 2024 | msn.comKobayashi factory searched over deaths possibly linked to supplementsMarch 30, 2024 | msn.com5 dead and over 100 hospitalized from recalled Japanese health supplementsMarch 29, 2024 | msn.comWhat are 'beni-koji' products linked to Japan deaths?March 28, 2024 | msn.comA Japanese supplement pill is recalled after two people died and more than 100 were hospitalizedMarch 27, 2024 | msn.comUnicycive rises 4% on $50M private placementMarch 14, 2024 | msn.comPeople in Japan more worried about smell of others' excrement than their own: surveyMarch 3, 2024 | msn.com1 in 4 Japan primary school kids with hay fever's itchy eyes have trouble studyingFebruary 23, 2024 | msn.comOKYO Pharma Stock (NASDAQ:OKYO), Short Interest ReportFebruary 21, 2024 | benzinga.comOKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal painFebruary 9, 2024 | msn.comOKYO Shares Rise 12% After FDA Clearance for IND ApplicationFebruary 9, 2024 | morningstar.comMOKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary GoalJanuary 8, 2024 | markets.businessinsider.comOKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024January 5, 2024 | finance.yahoo.comEyepoint Pharmaceuticals stock soars on wet-AMD trial resultsDecember 4, 2023 | proactiveinvestors.comOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol VisitDecember 4, 2023 | finance.yahoo.comHC Wainwright & Co. Initiates Coverage of OKYO Pharma Limited - (OKYO) with Buy RecommendationNovember 3, 2023 | msn.comOKYO Pharma raises $5.84m via share issuanceOctober 31, 2023 | proactiveinvestors.comOKYO Pharma Announces $5.84 Million Cash Raise and Payables ReductionOctober 31, 2023 | finanznachrichten.deDry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage StudyOctober 5, 2023 | msn.comOKYO shares retreat 12% after rallying ahead of Phase 2 study updateOctober 5, 2023 | msn.comOKYO Pharma Reports Positive Safety Data Profile For OK-101 In Dry Eye DiseaseOctober 5, 2023 | markets.businessinsider.comOKYO Pharma phase II dry eye trial making encouraging progressOctober 5, 2023 | proactiveinvestors.comOKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED")October 5, 2023 | finance.yahoo.com Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OKYO Media Mentions By Week OKYO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OKYO News Sentiment▼0.001.09▲Average Medical News Sentiment OKYO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OKYO Articles This Week▼00▲OKYO Articles Average Week Get the Latest News and Ratings for OKYO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for OKYO Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Kodal Minerals News Today Marks Electrical Group News Today PowerHouse Energy Group News Today CyanConnode News Today Altitude Group News Today Revolution Beauty Group News Today OptiBiotix Health News Today AstraZeneca News Today GSK News Today Ithaca Energy News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OKYO) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share OKYO Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OKYO Stock Alerts